Tillkännagivande • Feb 12
Hanil Chemical Ind. Co., Ltd., Annual General Meeting, Mar 31, 2026 Hanil Chemical Ind. Co., Ltd., Annual General Meeting, Mar 31, 2026, at 09:01 Tokyo Standard Time. Location: auditorium, 47, sandan 3-ro 6-gil, seongmun-myeon, chungcheongnam-do, dangjin South Korea Upcoming Dividend • Dec 22
Upcoming dividend of ₩50.00 per share Eligible shareholders must have bought the stock before 29 December 2025. Payment date: 20 April 2026. The company is not currently making a profit and is not cash flow positive. Trailing yield: 0.6%. Lower than top quartile of South Korean dividend payers (3.6%). Lower than average of industry peers (1.3%). Declared Dividend • Nov 08
Dividend of ₩50.00 announced Dividend of ₩50.00 is the same as last year. Ex-date: 29th December 2025 Payment date: 20th April 2026 Dividend yield will be 0.6%, which is lower than the industry average of 1.7%. Sustainability & Growth Dividend is being paid despite the company being loss-making over the last 12 months and having no free cash flows available, indicating it may be using cash reserves or debt to pay the dividend. The dividend has decreased over the past 66 years, indicating a lack of growth and stability in payments. Tillkännagivande • Nov 07
Hanil Chemical Ind. Co., Ltd. announces Annual dividend, payable on April 20, 2026 Hanil Chemical Ind. Co., Ltd. announced Annual dividend of KRW 50.0000 per share payable on April 20, 2026, ex-date on December 29, 2025 and record date on December 31, 2025. Tillkännagivande • Feb 14
Hanil Chemical Ind. Co., Ltd., Annual General Meeting, Mar 31, 2025 Hanil Chemical Ind. Co., Ltd., Annual General Meeting, Mar 31, 2025, at 09:01 Tokyo Standard Time. Location: auditorium, 47, sandan 3-ro 6-gil, seongmun-myeon, chungcheongnam-do, dangjin South Korea Upcoming Dividend • Dec 20
Upcoming dividend of ₩50.00 per share Eligible shareholders must have bought the stock before 27 December 2024. Payment date: 28 April 2025. The company is not currently making a profit and is not cash flow positive. Trailing yield: 0.4%. Lower than top quartile of South Korean dividend payers (3.9%). Lower than average of industry peers (2.2%). New Risk • Dec 07
New major risk - Financial data availability The company's latest financial reports are more than a year old. Last reported fiscal period ended September 2012. This is considered a major risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. In the worst case scenario, it may be facing other major going concern issues jeopardizing its viability as a listed company. Currently, the following risks have been identified for the company: Major Risk Latest financial reports are more than 1 year old (reported September 2012 fiscal period end). Minor Risk Market cap is less than US$100m (₩33.7b market cap, or US$23.7m). Declared Dividend • Nov 23
Dividend of ₩50.00 announced Shareholders will receive a dividend of ₩50.00. Ex-date: 27th December 2024 Payment date: 28th April 2025 Dividend yield will be 0.5%, which is lower than the industry average of 1.7%. Reported Earnings • Nov 20
Third quarter 2024 earnings released: ₩730 loss per share (vs ₩661 loss in 3Q 2023) Third quarter 2024 results: ₩730 loss per share (further deteriorated from ₩661 loss in 3Q 2023). Revenue: ₩31.9b (up 14% from 3Q 2023). Net loss: ₩2.56b (loss widened 10% from 3Q 2023). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 83 percentage points per year, which is a significant difference in performance. Reported Earnings • Aug 17
Second quarter 2024 earnings released: ₩157 loss per share (vs ₩758 loss in 2Q 2023) Second quarter 2024 results: ₩157 loss per share (improved from ₩758 loss in 2Q 2023). Revenue: ₩31.5b (down 1.3% from 2Q 2023). Net loss: ₩553.6m (loss narrowed 79% from 2Q 2023). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 81 percentage points per year, which is a significant difference in performance. New Risk • May 23
New major risk - Revenue and earnings growth Earnings have declined by 6.5% per year over the past 5 years. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are declining over an extended period, then in most cases the share price will decline over time unless the company can turn around its fortunes. A trend of falling earnings can be very difficult to turn around. If the company is well already established it may also be a sign the company has matured and is in decline. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 6.5% per year over the past 5 years. Minor Risk Market cap is less than US$100m (₩48.1b market cap, or US$35.3m). Reported Earnings • Mar 22
Full year 2023 earnings released: ₩3,477 loss per share (vs ₩1,468 profit in FY 2022) Full year 2023 results: ₩3,477 loss per share (down from ₩1,468 profit in FY 2022). Revenue: ₩121.9b (down 22% from FY 2022). Net loss: ₩12.2b (down 337% from profit in FY 2022). Over the last 3 years on average, earnings per share has fallen by 36% per year but the company’s share price has remained flat, which means it is well ahead of earnings. Upcoming Dividend • Dec 20
Upcoming dividend of ₩100.00 per share at 0.6% yield Eligible shareholders must have bought the stock before 27 December 2023. Payment date: 15 April 2024. The company is not currently making a profit and is not cash flow positive. Trailing yield: 0.6%. Lower than top quartile of South Korean dividend payers (3.5%). Lower than average of industry peers (1.8%). Valuation Update With 7 Day Price Move • Jul 05
Investor sentiment improves as stock rises 31% After last week's 31% share price gain to ₩26,700, the stock trades at a trailing P/E ratio of 43x. Average trailing P/E is 15x in the Chemicals industry in South Korea. Total returns to shareholders of 180% over the past three years. Valuation Update With 7 Day Price Move • May 03
Investor sentiment improves as stock rises 51% After last week's 51% share price gain to ₩31,250, the stock trades at a trailing P/E ratio of 25.3x. Average trailing P/E is 14x in the Chemicals industry in South Korea. Total returns to shareholders of 243% over the past three years. Valuation Update With 7 Day Price Move • Apr 13
Investor sentiment improves as stock rises 38% After last week's 38% share price gain to ₩22,950, the stock trades at a trailing P/E ratio of 18.6x. Average trailing P/E is 14x in the Chemicals industry in South Korea. Total returns to shareholders of 166% over the past three years. Upcoming Dividend • Dec 21
Upcoming dividend of ₩120 per share Eligible shareholders must have bought the stock before 28 December 2022. Payment date: 17 April 2023. Payout ratio is a comfortable 1.5% but the company is not cash flow positive. Trailing yield: 0.7%. Lower than top quartile of South Korean dividend payers (3.3%). Lower than average of industry peers (2.4%). Board Change • Nov 16
No independent directors No new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 3 experienced directors. No highly experienced directors. No independent directors (3 non-independent directors). was the last director to join the board, commencing their role in . The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of independent directors. Insufficient board refreshment. Valuation Update With 7 Day Price Move • Oct 26
Investor sentiment deteriorated over the past week After last week's 16% share price decline to ₩19,750, the stock trades at a trailing P/E ratio of 2.7x. Average trailing P/E is 12x in the Chemicals industry in South Korea. Total returns to shareholders of 52% over the past three years. Valuation Update With 7 Day Price Move • Sep 22
Investor sentiment deteriorated over the past week After last week's 26% share price decline to ₩26,000, the stock trades at a trailing P/E ratio of 3.6x. Average trailing P/E is 13x in the Chemicals industry in South Korea. Total returns to shareholders of 77% over the past three years. Valuation Update With 7 Day Price Move • Sep 07
Investor sentiment improved over the past week After last week's 22% share price gain to ₩27,450, the stock trades at a trailing P/E ratio of 3.8x. Average trailing P/E is 13x in the Chemicals industry in South Korea. Total returns to shareholders of 81% over the past three years. Valuation Update With 7 Day Price Move • Aug 23
Investor sentiment improved over the past week After last week's 20% share price gain to ₩23,750, the stock trades at a trailing P/E ratio of 3.6x. Average trailing P/E is 13x in the Chemicals industry in South Korea. Total returns to shareholders of 43% over the past three years. Valuation Update With 7 Day Price Move • Jul 08
Investor sentiment improved over the past week After last week's 27% share price gain to ₩21,700, the stock trades at a trailing P/E ratio of 3.3x. Average trailing P/E is 13x in the Chemicals industry in South Korea. Total returns to shareholders of 88% over the past three years. Valuation Update With 7 Day Price Move • Jun 21
Investor sentiment improved over the past week After last week's 19% share price gain to ₩19,950, the stock trades at a trailing P/E ratio of 3x. Average trailing P/E is 13x in the Chemicals industry in South Korea. Total returns to shareholders of 64% over the past three years. Board Change • Apr 27
No independent directors No new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 3 experienced directors. No highly experienced directors. No independent directors (3 non-independent directors). was the last director to join the board, commencing their role in . The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of independent directors. Insufficient board refreshment. Valuation Update With 7 Day Price Move • Apr 01
Investor sentiment improved over the past week After last week's 16% share price gain to ₩22,200, the stock trades at a trailing P/E ratio of 3.4x. Average trailing P/E is 15x in the Chemicals industry in South Korea. Total returns to shareholders of 99% over the past three years. Valuation Update With 7 Day Price Move • Mar 02
Investor sentiment improved over the past week After last week's 21% share price gain to ₩22,200, the stock trades at a trailing P/E ratio of 27.4x. Average trailing P/E is 16x in the Chemicals industry in South Korea. Total returns to shareholders of 90% over the past three years. Valuation Update With 7 Day Price Move • Jan 27
Investor sentiment deteriorated over the past week After last week's 16% share price decline to ₩15,500, the stock trades at a trailing P/E ratio of 19.1x. Average trailing P/E is 16x in the Chemicals industry in South Korea. Total returns to shareholders of 41% over the past three years. Upcoming Dividend • Dec 22
Upcoming dividend of ₩50.00 per share Eligible shareholders must have bought the stock before 29 December 2021. Payment date: 19 April 2022. Payout ratio is a comfortable 6.2% but the company is not cash flow positive. Trailing yield: 0.3%. Lower than top quartile of South Korean dividend payers (2.4%). Lower than average of industry peers (1.5%). Valuation Update With 7 Day Price Move • Nov 30
Investor sentiment deteriorated over the past week After last week's 20% share price decline to ₩14,350, the stock trades at a trailing P/E ratio of 17.7x. Average trailing P/E is 16x in the Chemicals industry in South Korea. Total returns to shareholders of 37% over the past three years. Valuation Update With 7 Day Price Move • Oct 27
Investor sentiment deteriorated over the past week After last week's 15% share price decline to ₩19,550, the stock trades at a trailing P/E ratio of 28.2x. Average trailing P/E is 20x in the Chemicals industry in South Korea. Total returns to shareholders of 71% over the past three years. Valuation Update With 7 Day Price Move • Oct 06
Investor sentiment deteriorated over the past week After last week's 17% share price decline to ₩15,000, the stock trades at a trailing P/E ratio of 21.7x. Average trailing P/E is 19x in the Chemicals industry in South Korea. Total returns to shareholders of 27% over the past three years. Is New 90 Day High Low • Mar 10
New 90-day high: ₩16,800 The company is up 78% from its price of ₩9,430 on 10 December 2020. The South Korean market is up 6.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 7.0% over the same period. Tillkännagivande • Feb 10
Hanil Chemical Ind. Co., Ltd., Annual General Meeting, Mar 25, 2021 Hanil Chemical Ind. Co., Ltd., Annual General Meeting, Mar 25, 2021, at 09:00 Korea Standard Time. Is New 90 Day High Low • Jan 04
New 90-day high: ₩10,550 The company is up 20% from its price of ₩8,820 on 06 October 2020. The South Korean market is up 21% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 22% over the same period. Is New 90 Day High Low • Dec 09
New 90-day high: ₩9,450 The company is up 3.0% from its price of ₩9,190 on 10 September 2020. The South Korean market is up 13% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 12% over the same period. Is New 90 Day High Low • Nov 20
New 90-day high: ₩9,400 The company is up 6.0% from its price of ₩8,900 on 21 August 2020. The South Korean market is up 10.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 14% over the same period. Is New 90 Day High Low • Sep 24
New 90-day low: ₩8,560 The company is down 10.0% from its price of ₩9,530 on 26 June 2020. The South Korean market is up 11% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 29% over the same period.